Literature DB >> 10424492

Salivary proteins in rheumatoid arthritis and Sjögren's syndrome: one-dimensional and two-dimensional electrophoretic studies.

J A Beeley1, K S Khoo.   

Abstract

Parotid saliva from patients with rheumatoid arthritis and Sjögren's syndrome contains elevated levels of multiple anionic proteins of pI approximately 3.75-4.75 and Mr approximately 32,000. Further studies on these components involving narrow range pH 3.5-5.0 immobilized pH gradients (IPGs) and two-dimensional (2D) electrophoresis with narrow- or broad-range IPGs in the first dimension have confirmed their association with these disorders. Immunoblotting showed that these proteins include multiple forms of tissue kallikrein. Treatment with neuraminidase results in removal of these anionic substances from the pH 3.75-4.75 region of gels, thereby indicating that heterogeneity arises from differences in sialation of the carbohydrate residues. The results of treatment with endo-beta-N-acetylglucosaminidase (Endo F) or peptide N-glycosidase (PNGase F) and comparison of the results with studies on human urinary kallikrein suggest that proteins other than kallikrein may also comigrate in the anionic region of gels and that deglycosylation of kallikrien is incomplete in the experimental conditions used, probably because of inadequate denaturation. The paper also reviews the limitations of current criteria used in the investigation of salivary gland function associated with connective tissue disorders and the diagnosis of these. It assesses the potential of electrophoresis in forming the basis of new diagnostic techniques and furthering the understanding of the nature of these diseases. The findings presented in this paper could make a key contribution to this.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10424492     DOI: 10.1002/(SICI)1522-2683(19990601)20:7<1652::AID-ELPS1652>3.0.CO;2-R

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  6 in total

1.  Complexity of the human whole saliva proteome.

Authors:  C Hirtz; F Chevalier; D Centeno; J C Egea; M Rossignol; N Sommerer; Deville de Périère
Journal:  J Physiol Biochem       Date:  2005-09       Impact factor: 4.158

2.  Sialometry and sialochemistry: diagnostic tools for Sjögren's syndrome.

Authors:  W W Kalk; A Vissink; F K Spijkervet; H Bootsma; C G Kallenberg; A V Nieuw Amerongen
Journal:  Ann Rheum Dis       Date:  2001-12       Impact factor: 19.103

3.  Quantitative proteomics of parotid saliva in primary Sjögren's syndrome.

Authors:  Kiran S Ambatipudi; Stephen Swatkoski; James J Moresco; Patricia G Tu; Andreea Coca; Jennifer H Anolik; Marjan Gucek; Igñacio Sanz; John R Yates; James E Melvin
Journal:  Proteomics       Date:  2012-09-10       Impact factor: 3.984

4.  Establishment of a novel diagnostic model for Sjögren's syndrome by proteomic fingerprinting.

Authors:  Yuhui Li; Xiaolin Sun; Xuewu Zhang; Yuqin Yang; Rulin Jia; Xu Liu; Ru Li; Yanying Liu; Zhanguo Li
Journal:  Clin Rheumatol       Date:  2014-09-02       Impact factor: 2.980

5.  Deregulation of the Kallikrein Protease Family in the Salivary Glands of the Sjögren's Syndrome ERdj5 Knockout Mouse Model.

Authors:  Petros Moustardas; Naomi Yamada-Fowler; Eirini Apostolou; Athanasios G Tzioufas; Maria V Turkina; Giannis Spyrou
Journal:  Front Immunol       Date:  2021-07-07       Impact factor: 7.561

6.  IL-17 sequestration via salivary gland gene therapy in a mouse model of Sjogren's syndrome suppresses disease-associated expression of the putative autoantigen Klk1b22.

Authors:  Changgong Wu; Zhimin Wang; Lee Zourelias; Hiteshi Thakker; Michael J Passineau
Journal:  Arthritis Res Ther       Date:  2015-08-06       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.